Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App





POC Plasmonic COVID-19 Test Uses Sensor Technology to Detect Coronavirus in Less than 45 Minutes

By LabMedica International staff writers
Posted on 08 Feb 2021
Scientists are developing a rapid point-of-care (POC) plasmonic COVID-19 test based on a cutting-edge sensor technology that would detect SARS-CoV-2 in less than 45 minutes with accuracy, sensitivity, and specificity comparable to the gold standard RT-PCR lab diagnostic. More...


RNA Disease Diagnostics, Inc. (RNADD; Ontario, Canada) has secured an exclusive global license to the sensor technology jointly owned by the University of Maryland, Baltimore (UMB; Baltimore, MD, USA) and the University of Maryland, Baltimore County (UMBC; Baltimore, MD, USA). The sensor technology will be used to support RNADD's development and manufacture of proprietary molecular disease diagnostic testing kits, enabling the company to quickly and accurately detect multiple infectious diseases, helping to lead to the prevention of their transmission and spread.

The POC plasmonic COVID-19 test currently under development for commercialization would be based on the sensor technology that is designed to accurately and affordably detect infectious diseases in less than 45 minutes. RNADD plans to leverage its proprietary Antisense RNA diagnostic platform across multiple diseases and to create highly accurate, quick, affordable, and minimally invasive disease diagnostic testing kits. The company’s initial focus is to deploy COVID-19 Antisense diagnostic Point of Care (POC) and Home Use Test (HUT) rapid diagnostic testing kits.

"Licensing this promising sensor technology from the universities enables us to advance a diagnostic test that may serve as a future gold standard in accurate and rapid COVID-19 testing. Our hope is that this work contributes to public health as countries begin to reopen following the massive vaccination efforts designed to help with prevention," said Allan Oberman, co-founder and chairman for RNADD.

Related Links:
RNA Disease Diagnostics, Inc.
University of Maryland, Baltimore
University of Maryland



Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.